PPT-Gavi’s Measles and Rubella Programme

MampRI Partners Meeting Michael F Thomas Director Vaccine Implementation September 2017 Washington DC Page 1 Reach every child Measles and Rubella support in Gavi countries by end of 2016. Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . Regional MR TAG . Nairobi, Kenya . June 2-3 , 2015 . Outline . Background . Epidemiology of Rubella . Strategic options for rubella control AFR . MR introduction progress noted issues related to MR introduction in AFR . Tenth Annual  Measles Initiative Meeting . September 13-14, 2011 Washington, DC. Sergei Deshevoi. WHO European Region . 2. Presentation outline. Regional goal and strategy. Progress towards goal. Challenges in reaching the goal in 2015. Global Measles and Rubella . Strategic Plan 2012 – 2020 . W. . A. . Orenstein, . MD. Measles and Rubella Management Meeting,. Geneva, June 2016. Outline. Strategic Plan . 2012-2020. Rationale and objective for Midterm Review. Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . Global Measles and Rubella . Strategic Plan 2012 – 2020 . W. . A. . Orenstein, . MD. Measles and Rubella Management Meeting,. Geneva, June 2016. Outline. Strategic Plan . 2012-2020. Rationale and objective for Midterm Review. Dr. Kimberly M. Thompson. Kid Risk, Inc., www.kidrisk.org. Topics. Context. I. ntegrated dynamic disease and economic . modeling. Discussion. http://www.wpro.who.int/vietnam/topics/immunization/measles_rubella/measles_rubella_big.png?ua=1. . Mona Aryal. HOD, Health Service Department. Nepal Red Cross Society. National Headquarter. . Nepal Red Cross Society’s Initiative. Vision: . to . provide immediate relief to human suffering and reduce vulnerability, under the Fundamental Principles of the Red Cross, . South East Asia Region. 1. 21 June 2016. Geneva, Switzerland. Regional Measles and Rubella Goals. 66th Meeting of the SEAR Regional Committee in September 2013 in New Delhi resolved . to adopt . the goal of . Dr. Kimberly M. Thompson. 11. th. Annual Measles and Rubella Partners Meeting. September 19, 2012. Acknowledgments. World Health Organization (WHO) Contract PO 200470477 APW . Radboud. . Duintjer. . Measles and Rubella Annual Partners Meeting, September 15-16 2015. Background. The MRI FRR is developed by the M&RI FRR/RMAWG. Country population data is drawn from UNDP estimates. Vaccine type and timing of SIAs is from countries . Hotel Royal, Geneva, Switzerland, 21-23 June 2016. Paul Rota,. Measles, Mumps, Rubella, Herpesviruses Laboratory Branch, CDC . par1@cdc.gov. . National Center for Immunization & Respiratory Diseases. MEA R) VACCINE What is the measles, mump and rubella (MMR) vaccine? The MMR vaccine protects against three diseases: measles, mumps and rubella (german measles). The vaccine is approved by He alth C  .  . Frequently Asked Questions. For Use of Teachers. Government of India has decided to introduce. measles-rubella (MR). vaccine. . The vaccine will be launched through a campaign,. to be followed by inclusion of the MR vaccine.